Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL).

It has previously been reported that the expression of the complement receptors CR1 (CD35) and CR2 (CD21) on malignant B cells in CLL is reduced compared with the expression on normal B cells, while deposition of complement C3 fragments, as a consequence of alternative pathway (AP) activation of com...

Full description

Saved in:
Bibliographic Details
Main Authors: Marquart, H V, Grønbaek, K, Christensen, B E, Svehag, S E, Leslie, R G
Format: Artigo
Language:Inglês
Published: 1995
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1553367/
https://ncbi.nlm.nih.gov/pubmed/8536375
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items